Response

Re: Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido: North Central Cancer Treatment Group Protocol N02C3

Debra L. Barton, Jeff A Sloan, Charles Lawrence Loprinzi, Rui Qin

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1482
Number of pages1
JournalJournal of the National Cancer Institute
Volume100
Issue number20
DOIs
StatePublished - Oct 2008

Fingerprint

Antineoplastic Protocols
Libido
Testosterone
Randomized Controlled Trials
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{9f824496030d41e8a7a1c0b62620ddff,
title = "Response: Re: Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido: North Central Cancer Treatment Group Protocol N02C3",
author = "Barton, {Debra L.} and Sloan, {Jeff A} and Loprinzi, {Charles Lawrence} and Rui Qin",
year = "2008",
month = "10",
doi = "10.1093/jnci/djn312",
language = "English (US)",
volume = "100",
pages = "1482",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "20",

}

TY - JOUR

T1 - Response

T2 - Re: Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido: North Central Cancer Treatment Group Protocol N02C3

AU - Barton, Debra L.

AU - Sloan, Jeff A

AU - Loprinzi, Charles Lawrence

AU - Qin, Rui

PY - 2008/10

Y1 - 2008/10

UR - http://www.scopus.com/inward/record.url?scp=54149119003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54149119003&partnerID=8YFLogxK

U2 - 10.1093/jnci/djn312

DO - 10.1093/jnci/djn312

M3 - Article

VL - 100

SP - 1482

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 20

ER -